HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Umeda, Y. Articles by Hayashi, H. Search for Related Content PubMed PubMed Citation Articles by Umeda, Y. Articles by Hayashi, H. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 42, 1214-1219, August 2001
Copyright © 2001 by Lipid Research, Inc.

Original Article

Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine

Correspondence to: Hiroshi Hayashi, To whom correspondence should be addressed., zh2h-hys{at}asahi-net.or.jp (E-mail)

This study was designed to determine whether gemfibrozil inhibits intestinal lipid absorption. Male Sprague-Dawley rats received an oral dose of 30 mg gemfibrozil/kg body weight for 14 days. Mesenteric lymph cannulation was performed, and a lipid infusion containing 40 µmol/h (35.4 mg/h) of radiolabeled triolein and 2.74 µmol/h (1.06 mg/h) of radiolabeled cholesterol with the addition of 1 mg/h of gemfibrozil was infused intraduodenally at a rate of 3 ml/h for 8 h. The lymph was collected, and the radioactivity levels of the lumen and gut mucosa were measured after the infusion. Lymph cholesterol transport was depressed in gemfibrozil-treated rats, in terms of mass measurements as well as radioactivity in a lesser degree. More radioactive cholesterol remained in the proximal portion of the intestinal lumen and mucosa in the treated rats than in the control rats. More radioactive triglycerides also remained in the proximal intestinal lumen of treated rats, although no difference in lymphatic triglyceride transport was observed between the groups. A significant portion of the radioactive cholesterol remained in the lumen in the gemfibrozil-treated rats. Gemfibrozil increased biliary cholesterol excretion.

Thus, this study shows that gemfibrozil inhibits cholesterol absorption in rat intestine. — Umeda, Y., Y. Kako, K. Mizutani, Y. Iikura, M. Kawamura, M. Seishima, and H. Hayashi. Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine. J. Lipid Res. 2001. 42: 1214;–1219.

Supplementary key words: fibrates, mesenteric lymph-fistula, Sprague-Dawley rats, triglyceride, lymph transport, biliary cholesterol

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. A. Valasek, S. L. Clarke, and J. J. Repa Fenofibrate reduces intestinal cholesterol absorption via PPAR{alpha}-dependent modulation of NPC1L1 expression in mouse J. Lipid Res., December 1, 2007; 48(12): 2725 - 2735. [Abstract] [Full Text] [PDF]

				B. L. Knight, D. D. Patel, S. M. Humphreys, D. Wiggins, and G. F. Gibbons Inhibition of cholesterol absorption associated with a PPAR{alpha}-dependent increase in ABC binding cassette transporter A1 in mice J. Lipid Res., November 1, 2003; 44(11): 2049 - 2058. [Abstract] [Full Text] [PDF]